The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: -0.10 (-6.06%)
Spread: 0.10 (6.667%)
Open: 1.65
High: 1.565
Low: 1.475
Prev. Close: 1.65
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Bank of Ireland CFO leaves; EMIS names new non-exec

Mon, 27th Sep 2021 14:17

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

EMIS Group PLC - Leeds, England-based healthcare software company - Names Denise Collis as an additional independent non-executive director. Collis will formally join the board on Friday. Collis is currently non-executive director, chair of the remuneration committee and senior independent director at SThree PLC and non-executive director and chair of the remuneration committee at Smiths News PLC.

----------

Bank of Ireland Group PLC - Dublin-based company - Chief Financial Officer Myles O'Grady steps down to take up a senior finance role in an organisation outside the financial services sector. O'Grady is expected to leave BoI in March 2022 and a process to appoint his successor will now commence. Myles joined BoI in June 2019 as finance director Ireland and was appointed CFO in October 2019 and a member of the board in January 2020.

----------

Empiric Student Property PLC - London-based real estate investment trust - Says Martin Ratchford has been appointed as an independent non-executive director from Friday. Ratchford has held the post of CFO at Frasers Property UK Ltd since June 2018. Empiric also says Jim Prower will resign as a director on the same day as part of a planned succession process.

----------

Fuller, Smith & Turner PLC - London-based brewery - Says Finance Director Adam Councell will step down from his role and from the board on Thursday. Neil Smith will succeed Councell. In order to ensure a smooth handover to Smith, Councell has agreed to provide appropriate support to the business on a consultancy basis until Smith joins the business on November 30.

----------

Powerhouse Energy Group PLC - Bingley, England-based company which is transforming plastics and waste into clean energy - Says Non-Executive Director Allan Vlah will step down at the end of 2021 to concentrate on his other business interests. Powerhouse Energy appoints Keith Riley as a non-executive director with immediate effect. Riley is currently proprietor & chief executive officer of Vismundi Ltd, a consultancy company providing services to the resources and waste management industry.

----------

LSL Property Services PLC - Newcastle, England-based surveying services company - Names James Mack as a non-executive director, with immediate effect. Mack currently serves as CFO & executive director at Barclays Bank UK PLC. James was previously CFO & executive director at Aldermore PLC and Aldermore Group PLC.

----------

Aberdeen Asian Income Fund Ltd - Chelmsford, England-based investment firm - Hires Robert Kirkby as an independent non-executive director with effect from November 1. "Robert is a former advisory partner at KPMG Channel Islands and a fellow of the Institute of Chartered Accountants with a background as a business leader and a track record of establishing a business, growing revenue and building a dynamic team," says Chair Charles Clarke.

----------

Harland & Wolff Group Holdings PLC - Belfast, Northern Ireland-based investment company - Says Clive Richardson, non-executive chair, is stepping down from the board. Richardson's notice period will run until mid-December 2021. Richardson has decided to step down to focus on other activities to which he is already committed, Harland & Wolff says. A formal process to appoint a successor has been initiated and, whilst this progresses, Malcolm Groat, currently chair of the Audit Committee, has been named as interim chair.

----------

Shield Therapeutics PLC - Newcastle, England-based pharmaceutical company - Names Jose Menoyo as vice president & chief medical officer with immediate effect. Prior to joining Shield, Menoyo served as Head of US Medical Affairs at Alexion Pharmaceuticals Inc.

----------

Corcel PLC - London-based natural resource exploration and development company - Names Henry Bellingham as an independent non-executive director, subject the successful conclusion of due diligence procedures. "Henry has a wealth of experience in the natural resources arena, and I am delighted to welcome him to the team at such an exciting time for the business," says Chair James Parsons.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
17 Apr 2019 18:11

DIRECTOR DEALINGS: Shield Therapeutics Chair Buys GBP40,000 In Shares

LONDON (Alliance News) - Shield Therapeutics PLC said Wednesday Chair James Karis bought 50,000 shares in the company.Karis acquired 46,000 shares at GBP0.815 on Monday, then acquired a at

Read more
3 Apr 2019 10:10

Shield Therapeutics narrows losses as it advances Feraccru to market

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced a decent improvement in revenue in its preliminary results on Wednesday, to £11.9m from £0.6m.

Read more
3 Apr 2019 09:56

Shield Therapeutics Cuts Loss In 2018; Licence Payment Lifts Revenue

LONDON (Alliance News) - Drug maker Shield Therapeutics PLC said Wednesday its 2018 loss narrowed significantly as revenue surged on a licence payment boost amid a year of "transition" a

Read more
14 Mar 2019 15:52

Shield Therapeutics Secures Positive Decision On Feraccru's Patent

LONDON (Alliance News) - Shield Therapeutics PLC on Thursday said its Feraccru patent met the requirements of the European Patent Convention, which will continue to provide protection to Feraccru

Read more
4 Mar 2019 11:26

Shield Therapeutics upbeat on latest Feraccru trial results

(Sharecast News) - Commercial stage pharmaceutical company Shield Therapeutics announced positive results from the AEGIS-H2H clinical trial on Monday, which compared 'Feraccru' (ferric maltol) - a novel oral iron replacement therapy - to 'Ferinject' (ferric carboxymaltose - FCM), the market-leading intravenously delivered iron replacement therapy.

Read more
29 Jan 2019 11:21

Shield Therapeutics Gets Positive Results From Feraccru Study

LONDON (Alliance News) - Shield Therapeutics PLC on Tuesday reported positive results from a long-term study of its lead treatment for iron deficiency, Ferracru.Shares in the company were a

Read more
29 Jan 2019 10:02

Shield Therapeutics upbeat on results of latest Feraccru study

(Sharecast News) - Commercial stage pharmaceutical company Shield Therapeutics announced positive results from the open-label extension phase of the AEGIS-CKD pivotal study of 'Feraccru' on Tuesday.

Read more
24 Jan 2019 14:16

Shield Therapeutics Expects 2018 Revenue Growth On Licence Payments

LONDON (Alliance News) - Shield Therapeutics PLC on Thursday said it expects its revenue to surge in 2018 on the back of licence payments for its Feraccru capsules.The pharmaceutical has in

Read more
24 Jan 2019 10:02

Shield Therapeutics revenues surge following commercialisation deal

(Sharecast News) - Shield Therapeutics saw revenues rocket in the second half of its trading year following a commercialisation agreement with European pharmaceutical specialist Norgine.

Read more
22 Jan 2019 13:35

Shield Therapeutics Appoints Director James Karis As Chair

LONDON (Alliance News) - Shield Therapeutics PLC said Tuesday that it has promoted board member James Karis to be non-executive chair with immediate effect.Karis has served on Shield's

Read more
22 Jan 2019 09:56

Shield Therapeutics promotes Karis to chairman

(Sharecast News) - Commercial stage pharmaceutical outfit Shield Therapeutics elevated James Karis to the role of non-executive chairman on Tuesday.

Read more
13 Dec 2018 11:57

FDA gives target date for Shield's Feraccru application

(Sharecast News) - Commercial stage pharmaceutical company Shield Therapeutics announced on Thursday that the US Food and Drug Administration (FDA) has confirmed that the target date for completion of the New Drug Application (NDA) review of 'Feraccru', under the terms of the Prescription Drug User Fee Act, would be 27 July 2019.

Read more
5 Dec 2018 13:07

Shield Therapeutics' Feraccru treatment launched in UK

(Sharecast News) - Shield Therapeutics' treatment for iron deficiency in adults, Feraccru, was launched in the UK on Wednesday by specialist pharmaceutical company Norgine.

Read more
5 Dec 2018 11:57

Shield Therapeutics Partner Norgine Launches Feraccru In UK

LONDON (Alliance News) - Shield Therapeutics PLC said Wednesday that Norgine BV has launched the company's treatment for iron deficiency, Ferracru, in the UK.In September 2018, Shield,

Read more
24 Sep 2018 14:30

DIRECTOR DEALINGS: Shield Therapeutics Boss Sterritt Buys More Stock

LONDON (Alliance News) - Shield Therapeutics PLC on Monday said Chief Executive Carl Sterritt bought more shares in the company in a deal on Friday last week.Sterritt pruchased 88,235 at 34

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.